Search results for "Highlights"


 
Results 211 - 220 of about 465 for "Highlights".
Sort by: Relevance | Newest | Oldest

Sulfonylureas not supported as second-line treatment for type 2 diabetes

Risk for major adverse cardiovascular events and all-cause mortality was higher when a sulfonylurea was added to metformin compared to other typical second- or third-line therapy options in a recent Danish study.
https://diabetes.acponline.org/archives/2020/04/10/1.htm
10 Apr 2020

Insulin initiation in the hospital associated with death, ED visits, readmissions in older patients

The study authors noted that older patients who begin insulin therapy while hospitalized are a vulnerable population for whom additional resources are needed during the transition to outpatient care.
https://diabetes.acponline.org/archives/2019/03/08/2.htm
8 Mar 2019

Consensus report updates evidence on managing hyperglycemia in patients with type 2 diabetes

The American Diabetes Association and the European Association for the Study of Diabetes updated their 2018 recommendations based on trials published in 2019.
https://diabetes.acponline.org/archives/2020/01/10/1.htm
10 Jan 2020

Patients with late-onset type 1 diabetes commonly treated as having type 2 diabetes

An analysis of patients with insulin-treated diabetes found that 38% of those with late-onset type 1 diabetes did not receive insulin at diagnosis, nearly half of whom reported a type 2 diabetes diagnosis.
https://diabetes.acponline.org/archives/2019/05/10/3.htm
10 May 2019

Poor glycemic control associated with fracture in type 1 but not type 2 diabetes

Patients with type 1 diabetes and a mean three-year HbA1c level greater than 8.0% had a higher fracture risk than those with a mean three-year HbA1c level of 7.0% or less.
https://diabetes.acponline.org/archives/2019/02/08/3.htm
8 Feb 2019

SGLT2 inhibitors, GLP-1 receptor agonists compared for CV, renal outcomes

Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with fewer hospitalizations for heart failure and slower progression of kidney disease while glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk of stroke.
https://diabetes.acponline.org/archives/2019/03/08/3.htm
8 Mar 2019

AHA issues statement on coronary artery disease management in patients with diabetes

The American Heart Association (AHA) addressed use of antithrombotics, hypertension drugs, and cholesterol therapies in patients with stable coronary artery disease and diabetes, among other recommendations.
https://diabetes.acponline.org/archives/2020/05/08/1.htm
8 May 2020

Glycemic control worse over time in type 2 patients who decline insulin, study finds

In adults with uncontrolled type 2 diabetes who initially declined insulin versus those who initially accepted, median time to an HbA1c level below 7.0% was 50 months versus 38 months.
https://diabetes.acponline.org/archives/2020/03/13/1.htm
13 Mar 2020

3 actions may help reluctant patients begin insulin therapy for type 2 diabetes

Patients' perceived helpfulness of certain actions by health care professionals was linked to earlier insulin initiation and greater insulin continuation over time, a survey found.
https://diabetes.acponline.org/archives/2019/02/08/2.htm
8 Feb 2019

SGLT2 inhibitors associated with increased risk of amputations, diabetic ketoacidosis

Sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists had similar rates of other adverse events, including bone fracture, acute kidney injury, serious urinary tract infection, venous thromboembolism, and acute pancreatitis.
https://diabetes.acponline.org/archives/2018/12/14/3.htm
14 Dec 2018

Result Page: Prev   17   18   19   20   21   22   23   24   25   26   Next